Praveg Limited - Due diligence report

A 360° intelligence report on Sword & Sheild Pharma: trust score, financial health, credit view, compliance, directors, growth and distress …

1995-02-28 Daskroi, Gujarat Active Listed Active Compliant
View plans Plan
PL Praveg Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sword & Sheild Pharma — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Sword & Sheild Pharma is assessed as Moderate with a Trust Score of 74/100. Sword & Sheild Pharma is an active public limited indian non-government company incorporated in 1995, operating in the Travel and Hospitality sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 12 Jul 2026 from the latest processed filings. Praveg Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
40/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 1 open (11.25 cr) · 8 satisfied (13.18 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Indian Bank2 48.0 cr
Hdfc Bank Limited2 48.0 cr
Others3 48.0 cr
The Naroda Nagarik Co. Op. Bank Ltd.1 48.0 cr
Compliance Score: 40/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: NSDL, BSE.
  • Litigation present in 3 court forum(s).
  • 1 auditor resignation(s) filed - latest: JANAK SONI & ASSOCIATES on 2015-09-03.
  • 10 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 75/100
NameDIN / PANDesignationAppointedTenureDIN status
RAJENDRAKUMAR CHATURBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
ALPESHKUMAR PARSHOTTAMBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
KALPESH RAMANLAL PATEL 01234567 Director 01/04/2018 6 yrs Approved
MUKESHKUMAR SOHANRAM CHAUDHARY 01234567 Director 01/04/2018 6 yrs Approved
PARIKH BIJAL KIRAN 01234567 Director 01/04/2018 6 yrs Approved
POOJA HEMANG KHAKHI 01234567 Director 01/04/2018 6 yrs Approved
KEYOOR MADHUSUDAN BAKSHI 01234567 Director 01/04/2018 6 yrs Approved
DHARMENDRAKUMAR MANILAL SONI 01234567 Director 01/04/2018 6 yrs Approved
AJIT KUMAR PANDA 01234567 Director 01/04/2018 6 yrs Approved
MUKESHKUMAR SOHANRAM CHAUDHARY 01234567 Director 01/04/2018 6 yrs Approved
PATEL VISHNUKUMAR VITTHALDAS 01234567 Director 01/04/2018 6 yrs Approved
DILIPKUMAR PATEL CHUNILAL 01234567 Director 01/04/2018 6 yrs Approved
  • 12 directors on the board.
  • No disqualified or deactivated DINs.
  • 6 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Group entityRelationship% held
Praveg Adalaj Tourism Infrastructure Private Limited Subsidiary Company 74.00%
Praveg Communications (aus) Pty Ltd Subsidiary Company 74.00%
Praveg Communications Usa Inc Subsidiary Company 74.00%
Praveg Safaris Kenya Limited Subsidiary Company 74.00%
Praveg Safaris Tanzania Limited Subsidiary Company 74.00%
Sardar Sarovar Tourism Opportunities Joint Ventures 74.00%

Key managerial personnel: DHARMENDRAKUMAR MANILAL SONI (CFO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 31+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Compliance score is weak (40/100).
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 11.25 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
12 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Feb 2025
Charge satisfied
Indian Bank
21 Oct 2024
Charge created
State Bank Of India - 11.25 cr
30 Sep 2024
Director appointed
DILIPKUMAR PATEL CHUNILAL (Director)
29 Sep 2024
Director ceased
ALPESHKUMAR PARSHOTTAMBHAI PATEL
Director ceased
KALPESH RAMANLAL PATEL
10 Aug 2024
Director appointed
ALPESHKUMAR PARSHOTTAMBHAI PATEL (Director)
Director appointed
KALPESH RAMANLAL PATEL (Director)
17 May 2024
Charge satisfied
Others
08 Jan 2024
Charge satisfied
Others
21 Sep 2023
Director ceased
BHUMIT VINODKUMAR PATEL
Director ceased
PARIKH BIJAL KIRAN
Director ceased
POOJA HEMANG KHAKHI
16 Sep 2023
Director ceased
PARASKUMAR MANEKLAL PATEL
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
12 active director(s) / partner(s); board looks stable and experienced.
10 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Hb Estate Developers L99999HR1994PLC034146 Gurgaon, Haryana, India
Aakriti Hotels Private Limited U74899DL1995PTC069908 New Delhi, Delhi, India
Treebo U74900KA2015PTC080316 Bangalore South, Karnataka, India
Viceroy Hotels L55101TG1965PLC001048 Khairatabad, Telangana, India
Benares Hotels L55101UP1971PLC003480 Uttar Pradesh, Uttar Pradesh, India
Charishma Hotels Private Limited U55207KA2007PTC042783 Bangalore, Karnataka, India
Sayaji Hotels L51100GJ1982PLC162541 Vadodara, Gujarat, India
Tamara U07010KA2005PTC037101 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sword & Sheild Pharma before audits and certifications: compliance score 40/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sword & Sheild Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Sword & Sheild Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Sword & Sheild Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Sword & Sheild Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sword & Sheild Pharma an active company?

Sword & Sheild Pharma has MCA status “Active” with a compliance score of 40/100 (Caution Indicated).

Is Sword & Sheild Pharma financially healthy?

Sword & Sheild Pharma has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Sword & Sheild Pharma?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sword & Sheild Pharma?

Promoters hold a minority stake - exact percentages are in the full report. 12 active director(s) are on record.

Does Sword & Sheild Pharma have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.

Is Sword & Sheild Pharma up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 40/100 (Caution Indicated).

Is it risky to lend to Sword & Sheild Pharma?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.